Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Sinucleanse Kit	NCIT_C29455	[A system containing saline solution that is used to wash and clear nasal passages and sinuses and to moisten dry nasal passages. Sinucleanse kit relieves nasal and sinus symptoms related to the cold, flu and allergies.]
Methocarbamol-based Formulation	NCIT_C29456
Sodium Bicarbonate	NCIT_C29457	[The monosodium salt of carbonic acid with alkalinizing and electrolyte replacement properties. Upon dissociation, sodium bicarbonate forms sodium and bicarbonate ions. Ion formation increases plasma bicarbonate and buffers excess hydrogen ion concentration, resulting in raised blood pH.]
Sodium Cromoglycate	NCIT_C29458
Past Seven Days Unable to Have Orgasm	NCIT_C132220	[A question about whether or not an individual was unable to have an orgasm or climax.]
Sodium Phosphate	NCIT_C29459	[An inorganic compound used as a laxative, dietary supplement and for electrolyte-replacement purposes. Phosphate, a predominant intracellular anion, plays an important role in energy storage, osteoblastic and osteoclastic activities, regulating serum calcium concentrations, and numerous cellular phosphate-transfer reactions. Sodium phosphate increases fluidity of the intestinal contents by retention of water by osmotic forces, thereby indirectly inducing intestinal smooth muscle constriction. Sodium phosphate is also used in the renal excretion of hydrogen ions while promoting the reabsorption of sodium ions.]
Not Sexually Active	NCIT_C132221	[A response indicating that an individual is not or was not sexually active.]
Prefer Not to Answer	NCIT_C132222	[A response indicating that an individual prefers or preferred not to answer.]
Supplemental Testing	NCIT_C132223	[Additional, or secondary, testing done to confirm a preliminary result.]
TRAIL Receptor Agonist ABBV-621	NCIT_C146854	[A fusion protein composed of a tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor agonist consisting of six receptor binding domains (RBDs) of TRAIL fused to the Fc-domain of a human immunoglobulin G1 (IgG1) antibody, with potential pro-apoptotic and antineoplastic activities. Upon administration of TRAIL receptor agonist ABBV-621, this fusion protein binds to TRAIL-receptors, pro-apoptotic death receptors (DRs) TRAIL-R1 (death receptor 4; DR4) and TRAIL-R2 (death receptor 5; DR5), expressed on tumor cells, thereby inducing tumor cell apoptosis. ABBV-621 is designed to maximize receptor clustering for optimal efficacy. TRAIL, a member of the TNF superfamily of cytokines, plays a key role in the induction of apoptosis through TRAIL-mediated death receptor pathways.]
Salvage Surgery	NCIT_C146855	[Surgical treatment undertaken after failure of initial surgery or failure of other modalities.]
Surgical Procedure by Type	NCIT_C161601	[A categorization of surgical procedures by type or purpose.]
Locally Advanced Angiosarcoma	NCIT_C146856	[An angiosarcoma that has spread from its original site of growth to nearby tissues or lymph nodes.]
Locally Advanced Sarcoma	NCIT_C153071	[Sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes.]
Metastatic Angiosarcoma	NCIT_C8708	[An angiosarcoma that has spread to another anatomical site.]
Locally Advanced Epithelioid Hemangioendothelioma	NCIT_C146857	[An epithelioid hemangioendothelioma that has spread from its original site of growth to nearby tissues or lymph nodes.]
Metastatic Epithelioid Hemangioendothelioma	NCIT_C146858	[An epithelioid hemangioendothelioma which has spread from its original site of growth to another anatomic site.]
Locally Advanced Malignant Neoplasm	NCIT_C8524	[A malignant neoplasm that has spread from its original site of growth to nearby tissues or lymph nodes.]
Epithelioid Hemangioendothelioma	NCIT_C3800	[A low-grade malignant blood vessel neoplasm. It is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.]
L-methylfolate	NCIT_C107240	[A nutritional supplement containing the biologically active form of the B9 vitamin folate, 5-methyltetrahydrofolate (L-methylfolate), with potential antineoplastic activity. Upon administration, L-methylfolate is able to provide methyl groups allowing an increase in the level of DNA methylation in the promoter regions of certain tumor-promoting genes, thereby reversing the DNA hypomethylation of these genes and inactivating them. This may result in a decrease of both tumor cell proliferation and tumor progression. In addition, administration of L-methylfolate may sensitize tumor cells to the cytotoxic effects of other chemotherapeutic agents. Unlike folic acid, L-methylfolate is able to cross the blood brain barrier and could be beneficial in the treatment of brain tumors. DNA hypomethylation of certain genes leads to chromosome instability and contributes to tumor development.]